2m 2m 2m 2m 2m 2m 2m
Align Technology (ALGN)
NASDAQ
$179.60-$0.99 (-0.55%)
Price as of Jul 13, 2026 7:56 PM EDT- $12.9BMarket Cap
- -9.39%1-Year Change
- Medical Instruments & SuppliesIndustry
Align Technology (ALGN)
$179.60-$0.99 (-0.55%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.0B +0.90% | 4.0B +3.54% | 3.9B +3.42% | 3.7B -5.51% | |
Cost of Revenue | 1.3B +10.34% | 1.2B +3.85% | 1.2B +4.95% | 1.1B +8.22% | |
Gross Profit | 2.7B -3.15% | 2.8B +3.41% | 2.7B +2.78% | 2.6B -10.27% | |
Sales and Marketing Expense | 1.8B -0.42% | 1.8B +3.51% | 1.7B +1.73% | 1.7B -2.00% | |
Research and Development Expense | -369.9M +1.57% | -364.2M +5.01% | -346.8M +13.62% | -305.3M +21.95% | |
Depreciation and Amortization Expense | 237.4M +63.71% | 145.0M +1.85% | 142.4M +13.20% | 125.8M +15.69% | |
Total Operating Expenses | 2.2B -1.20% | 2.2B +6.20% | 2.1B +3.63% | 2.0B +1.65% | |
Operating Profit | 545.8M -10.18% | 607.6M -5.55% | 643.3M +0.12% | 642.6M -34.19% | |
Interest Income | 16.0M -20.64% | 20.2M +17.15% | 17.3M +221.56% | 5.4M +72.96% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 16.0M -20.64% | 20.2M +17.15% | 17.3M +221.56% | 5.4M +72.96% | |
Total Nonoperating Income and Expense | 23.5M +224.36% | -18.9M -2.60% | -19.4M -60.35% | -48.9M -248.56% | |
Income before Taxes | 585.3M -3.89% | 609.0M -5.03% | 641.2M +7.04% | 599.1M -40.83% | |
Income Taxes | 174.9M -6.75% | 187.6M -4.36% | 196.2M -17.40% | 237.5M -1.21% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 410.4M -2.61% | 421.4M -5.32% | 445.1M +23.09% | 361.6M -53.17% | |
Net Income from Continuing Operations Applicable to Common | 585.3M -3.89% | 609.0M -5.03% | 641.2M +7.04% | 599.1M -40.83% | |
Basic EPS and Net Income | 5.66 +0.53% | 5.63 -3.26% | 5.82 +25.97% | 4.62 -52.76% | |
Diluted EPS and Net Income | 5.65 +0.53% | 5.62 -3.27% | 5.81 +26.03% | 4.61 -52.43% | |
Basic Weighted Average Shares | 72.5M -3.12% | 74.9M -2.03% | 76.4M -2.26% | 78.2M -0.92% | |
Diluted Weighted Average Shares | 72.6M -3.21% | 75.0M -2.06% | 76.6M -2.36% | 78.4M -1.57% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.1B +4.89% | 1.0B +11.36% | 937.4M -0.49% | 942.0M -14.31% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 35.3M -38.64% | 57.5M -20.06% | |
Cash and Cash Equivalents and Short-Term Investments | 1.1B +4.89% | 1.0B +7.31% | 972.7M -2.69% | 999.6M -14.66% | |
Total Current Assets | 2.6B +4.98% | 2.5B +1.87% | 2.4B +0.92% | 2.4B -2.79% | |
Accumulated Depreciation | 767.3M +15.96% | 661.7M +20.14% | 550.8M +22.47% | 449.7M +25.24% | |
Property and Plant and Equipment and Net | 1.1B -10.99% | 1.3B -1.53% | 1.3B +4.79% | 1.2B +13.86% | |
Total Long-Term Assets | 278.0M +18.74% | 234.2M +81.97% | 128.7M +130.51% | 55.8M -2.93% | |
Total Assets | 6.2B +0.31% | 6.2B +2.15% | 6.1B +2.29% | 5.9B +0.10% | |
Income Taxes Payable | 68.2M -29.30% | 96.5M -17.37% | 116.7M -6.15% | 124.4M +5.35% | |
Total Short-Term Debt | N/A N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 1.9B -5.79% | 2.0B -1.38% | 2.1B +7.31% | 1.9B +0.09% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 113.8M -18.64% | 139.9M -19.16% | 173.1M -11.69% | 196.0M +12.24% | |
Total Liabilities | 2.2B -7.54% | 2.4B -3.70% | 2.5B +4.55% | 2.3B +1.17% | |
Retained Earnings | 2.5B -0.79% | 2.5B +1.50% | 2.4B -4.66% | 2.6B -2.01% | |
Total Stockholders Equity | 4.0B +5.12% | 3.9B +6.10% | 3.6B +0.81% | 3.6B -0.59% | |
Total Shares Outstanding | 71.4M -3.36% | 73.8M -1.63% | 75.1M -2.84% | 77.3M -1.83% | |
Cash Flow | |||||
Cash from Operating Activities | 593.2M -19.64% | 738.2M -6.05% | 785.8M +38.16% | 568.7M -51.50% | |
Capital Expenditures | 102.4M -11.36% | 115.6M -34.96% | 177.7M -39.12% | 291.9M -27.22% | |
Cash from Investing Activities | -112.4M -55.89% | -254.9M +30.09% | -195.9M -8.14% | -213.3M -62.14% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -464.6M +30.60% | -355.7M -40.55% | -598.3M +19.27% | -501.7M +9.46% | |
Financials Ratio | |||||
Gross Margin | 67.19% -4.01% | 70.00% -0.13% | 70.09% -0.62% | 70.52% -5.04% | |
Operating Margin | 13.53% -10.98% | 15.19% -8.78% | 16.66% -3.19% | 17.21% -30.35% | |
Return on Assets | 6.59% -3.79% | 6.85% -7.38% | 7.40% +21.64% | 6.08% -57.57% | |
Return on Equity | 10.39% -7.77% | 11.26% -8.49% | 12.31% +22.96% | 10.01% -55.55% | |
Revenue Growth | 0.90% -74.61% | 3.54% +3.61% | 3.42% +161.97% | -5.51% -109.21% | |
Current Ratio | 1.36 +11.43% | 1.22 +3.30% | 1.18 -5.95% | 1.26 -2.89% | |
Cash Ratio | 0.57 +11.34% | 0.51 +12.92% | 0.45 -7.28% | 0.49 -14.39% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow